Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigid Boland

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Annual Review of Medicine|January 27, 2025
Approach to Therapy for Chronic PouchitisMaia Kayal, Brigid Boland
Sexual Health|December 9, 2008
Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, KenyaMichele Montandon, Nuriye Nalan Sahin-Hodoglugil, Elizabeth Bukusi, et al.
Digestive Diseases and Sciences|September 3, 2020
Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel DiseaseMaria Barsky, Joseph Meserve, Helen Le, et al.
Research Square|April 1, 2024
Automated Spatial Omics Landscape Analysis Approach Reveals Novel Tissue Architectures in Ulcerative ColitisStephan Rogalla, Derek Holman, Samuel Rubin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2021
Spatial Evolution of Histologic and Endoscopic Healing in the Left and Right Colon in Patients With Ulcerative ColitisSushrut Jangi, Ariela K Holmer, Parambir S Dulai, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Functional Diversity of Memory CD8 T Cells is Spatiotemporally ImprintedMiguel Reina-Campos, Alexander Monell, Amir Ferry, et al.
Nature|January 22, 2025
Tissue-resident memory CD8 T cell diversity is spatiotemporally imprintedMiguel Reina-Campos, Alexander Monell, Amir Ferry, et al.
Alimentary Pharmacology & Therapeutics|July 14, 2020
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's diseaseMatthew Bohm, Ronghui Xu, Yiran Zhang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2020
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative ColitisDana Lukin, David Faleck, Ronghui Xu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Annual Review of Medicine|January 27, 2025
Approach to Therapy for Chronic PouchitisMaia Kayal, Brigid Boland
Sexual Health|December 9, 2008
Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, KenyaMichele Montandon, Nuriye Nalan Sahin-Hodoglugil, Elizabeth Bukusi, et al.
Digestive Diseases and Sciences|September 3, 2020
Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel DiseaseMaria Barsky, Joseph Meserve, Helen Le, et al.
Research Square|April 1, 2024
Automated Spatial Omics Landscape Analysis Approach Reveals Novel Tissue Architectures in Ulcerative ColitisStephan Rogalla, Derek Holman, Samuel Rubin, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 8, 2021
Spatial Evolution of Histologic and Endoscopic Healing in the Left and Right Colon in Patients With Ulcerative ColitisSushrut Jangi, Ariela K Holmer, Parambir S Dulai, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Functional Diversity of Memory CD8 T Cells is Spatiotemporally ImprintedMiguel Reina-Campos, Alexander Monell, Amir Ferry, et al.
Nature|January 22, 2025
Tissue-resident memory CD8 T cell diversity is spatiotemporally imprintedMiguel Reina-Campos, Alexander Monell, Amir Ferry, et al.
Alimentary Pharmacology & Therapeutics|July 14, 2020
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's diseaseMatthew Bohm, Ronghui Xu, Yiran Zhang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 11, 2020
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative ColitisDana Lukin, David Faleck, Ronghui Xu, et al.
Pageof 1